NSE - Delayed Quote INR
Themis Medicare Limited (THEMISMED.NS)
At close: October 22 at 3:30 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
4,029,780.00
3,766,324.00
3,444,550.00
3,913,480.00
2,293,325.00
Cost of Revenue
1,519,607.00
1,397,601.00
1,209,968.00
1,519,946.00
805,330.00
Gross Profit
2,510,173.00
2,368,723.00
2,234,582.00
2,393,534.00
1,487,995.00
Operating Expense
2,037,056.00
1,976,134.00
1,665,021.00
1,531,982.00
1,078,527.00
Operating Income
473,117.00
392,589.00
569,561.00
861,552.00
409,468.00
Net Non Operating Interest Income Expense
-84,017.00
-85,373.00
-90,171.00
-81,690.00
-123,004.00
Pretax Income
622,734.00
534,432.00
725,149.00
952,620.00
413,307.00
Tax Provision
122,578.00
99,197.00
156,141.00
223,813.00
56,278.00
Net Income Common Stockholders
500,160.00
435,238.00
569,010.00
728,808.00
357,030.00
Diluted NI Available to Com Stockholders
500,157.00
435,235.00
569,008.00
728,808.00
357,030.00
Basic EPS
5.43
4.73
6.18
7.92
3.89
Diluted EPS
5.43
4.72
6.17
7.91
3.88
Basic Average Shares
92,096.53
92,040.12
92,027.70
92,002.70
91,884.54
Diluted Average Shares
92,145.54
92,205.73
92,180.11
92,175.35
91,914.23
Rent Expense Supplemental
--
21,692.00
18,077.00
9,794.00
8,338.00
Total Expenses
3,556,663.00
3,373,735.00
2,874,989.00
3,051,928.00
1,883,857.00
Net Income from Continuing & Discontinued Operation
500,160.00
435,238.00
569,010.00
728,808.00
357,030.00
Normalized Income
499,434.75
434,502.61
568,594.91
728,548.65
356,867.60
Interest Income
--
8,393.00
5,473.00
6,055.00
4,121.00
Interest Expense
74,919.00
76,275.00
79,902.00
65,369.00
109,657.00
Net Interest Income
-84,017.00
-85,373.00
-90,171.00
-81,690.00
-123,004.00
EBIT
697,653.00
610,707.00
805,051.00
1,017,989.00
522,964.00
EBITDA
813,927.00
733,170.00
909,999.00
1,112,787.00
608,435.00
Reconciled Cost of Revenue
1,519,607.00
1,397,601.00
1,209,968.00
1,519,946.00
805,330.00
Reconciled Depreciation
116,274.00
122,463.00
104,948.00
94,798.00
85,471.00
Net Income from Continuing Operation Net Minority Interest
500,160.00
435,238.00
569,010.00
728,808.00
357,030.00
Total Unusual Items Excluding Goodwill
903.00
903.00
529.00
339.00
188.00
Total Unusual Items
903.00
903.00
529.00
339.00
188.00
Normalized EBITDA
813,024.00
732,267.00
909,470.00
1,112,448.00
608,247.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
177.75
167.61
113.91
79.65
25.60
3/31/2021 - 4/2/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
JUBLPHARMA.NS Jubilant Pharmova Limited
1,127.35
-4.74%
ALKEM.NS Alkem Laboratories Limited
6,110.25
-0.78%
GUFICBIO.NS Gufic Biosciences Limited
435.95
-3.15%
FDC.NS FDC Limited
528.55
-1.53%
SHILPAMED.NS Shilpa Medicare Limited
794.80
-4.34%
SPARC.NS Sun Pharma Advanced Research Company Limited
208.06
-0.59%
RPGLIFE.NS RPG Life Sciences Limited
2,594.60
-5.65%
SIGACHI.NS Sigachi Industries Limited
46.27
-5.80%
AUROPHARMA.NS Aurobindo Pharma Limited
1,447.60
-0.87%
GLAND.NS Gland Pharma Limited
1,647.60
-1.65%